Hennemann 等在对放射性碘治疗甲状腺毒症做了非常有用的调查后,提出“用~(131)碘治疗甲状腺毒症与甲状腺癌的发生无关”。作者认为,上述结论是根据此地区最大规模的调查做出的,很容易给那些接受~(131)碘疗法的患者一种假的安全感。Dobyns 等曾就35,000例患者治疗的情况,对这个问题提出了多种解释。其中治疗1年后的病人。有8例死于甲状腺癌,接受~(131)碘治疗的22,505例病人中有7例,这些病人随访时间平均为8年,用外科手术而不用~(131)碘治疗的10,940例病 Hennemann and other radioactive iodine in the treatment of thyrotoxicosis have done a very useful investigation, “131I iodine treatment of thyrotoxicosis has nothing to do with the occurrence of thyroid cancer.” The authors conclude that the above conclusion, based on the largest survey in the area, is likely to provide a false sense of security to those who receive ~ 131 iodine therapy. Dobyns et al. Had treated 35,000 patients and offered many explanations for the problem. One year after the treatment of patients. Seven of 22,505 patients who died of thyroid cancer and 131I treatment had an average follow-up of 8 years and 10,940 patients who underwent surgery without 131I treatment